Atomo Completes Capital Raise
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Atomo Diagnostics Ltd. has announced the completion of a capital raise through a placement and a share purchase plan, aiming to raise significant funds for its operations. The company has secured commitments for a substantial amount under the placement and plans to offer eligible shareholders the chance to participate in the share purchase plan. The funds will be used to expand the commercialization of Atomo's diagnostic tests and support operational growth. The announcement includes a timetable for the capital raising activities and outlines the terms of the share purchase plan.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Atomo Diagnostics
- FebriDx FDA CLIA wavier approval unlocks upside for Pascal
- Trading Halt
- Pause in Trading
- Response to ASX Price Query
- H1 FY26 Results Presentation
Later from Atomo Diagnostics
- Response to ASX Aware Letter
- Share Purchase Plan Results
- Managing Director & CEO Transition
- 2026 Appendix 4E and Annual Report
- Atomo Signs Agreement with Innovation Scientific
Follow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics